Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

M&A/IPOs

 

Carlyle acquires Knack RCM and EqualizeRCM

US private equity firm Carlyle has acquired a majority stake in two healthcare revenue cycle management (RCM) platforms: Knack RCM and EqualizeRCM. The investment is being made through Carlyle Asia Partners VI and Carlyle Asia Partners Growth II.

FutureLife partners with Alife Health

FutureLife, a pan-European IVF and genetics provider, has rolled out an AI platform across its 60 clinics in 16 countries through a partnership with US-based Alife Health, which modernises and personalises the IVF process using AI.

HBI 2026: Investing in the UK and Ireland

A panel entitled ‘Investing in the UK and Ireland’ at HBI’s 2026 conference discussed how the healthcare market in the UK and Ireland is being shaped by policy shifts, which include the latest 10-year plan from the National Health Service (NHS). 

Nordic Capital-backed LEO Pharma buys Replay

Private equity firm Nordic Capital-backed LEO Pharma, a provider of medical dermatology solutions, has acquired gene therapy company Replay, which develops gene therapies for rare genetic conditions Replay’s equity holders will receive $50 million upfront, with additional milestone payments and tiered single-digit royalties.

Doctolib buys Medicus and enters the UK

European healthtech group Doctolib has entered the UK market through the acquisition of London-based startup Medicus. The company plans to invest over £100 million (~$136 million) in the UK as part of its expansion.

TEC becomes joint owner of Quadrivio’s CareHub

The Equity Club (TEC), Italian international banking group Mediobanca’s club deal investment platform, has co-invested in a €50 million capital increase for Italian outpatient diagnostics provider CareHub, owned by private equity firm Quadrivio Group since 2024 via its Silver Economy Fund. Quadrivio and TEC will now co-own the operator. We spoke to Dario Di Iorio, Senior Investment Director at Quadrivio’s Silver Economy Fund, about the deal and the wider opportunity in Italy’s rapidly expanding private outpatient market.

Find Us